Drug firm Shilpa Medicare has received GMP compliance certificate from the Japanese health regulator, PMDA, for its two active pharmaceutical ingredient (API) plants in Karnataka.
The company has received GMP compliance certificate for two API sites in Karnataka from PMDA - Japan, Shilpa Medicare said in a BSE filing.
Established in 2004, Pharmaceuticals and Medical Devices Agency (PMDA) of Japan is tasked to protect the public health in Japan by assuring safety, efficacy and quality of pharmaceuticals and medical devices.
Shilpa Medicare shares today closed 0.23 per cent higher at Rs 437.50 on BSE.
